We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BQVXM815 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 363.50 | 352.10 | 374.90 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 0 | -6.69M | -1.9092 | -1.90 | 12.74M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 08/1/2025 | 11:49 | ALNC |  IN BRIEF: Hemogenyx Pharmaceuticals raises GBP340,000 for drug trial |
| 08/1/2025 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Placing to raise £340,000 |
| 02/1/2025 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Change of Company Secretary and Registered.. |
| 31/12/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Total Voting Rights |
| 30/12/2024 | 12:01 | ALNC | Hemogenyx opens first clinical site for leukaemia therapy trial |
| 30/12/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Opening of First Clinical Site |
| 19/12/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Ultrafast CAR-T Manufacturing |
| 10/12/2024 | 16:10 | UK RNS | Hemogenyx Pharmaceuticals PLC Admission of New Ordinary Shares and New ISIN |
| 09/12/2024 | 13:30 | UK RNS | Hemogenyx Pharmaceuticals PLC Result of Extraordinary General Meeting |
| 09/12/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Site Initiation Visit Completed |
1 Year Hemogenyx Pharmaceuticals Chart |
Intraday Hemogenyx Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
